• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ISLEEVE 14F; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ISLEEVE 14F; INTRODUCER, CATHETER Back to Search Results
Model Number 10445
Device Problems Difficult to Remove (1528); Material Integrity Problem (2978)
Patient Problem Vascular Dissection (3160)
Event Date 09/05/2022
Event Type  malfunction  
Event Description
It was reported that difficulty removing the delivery system through the introducer sheath and dissection occurred.Procedure summary: vascular access was obtained via a transfemoral approach.The severely calcified native aortic annulus was 21.9mm in diameter and mildly tortuous.A 14f isleeve introducer sheath was advanced into position.Balloon aortic valvuloplasty (bav) was performed with a non-bsc balloon catheter in accordance with the instructions for use (ifu).An acurate neo2 valve was prepared and loaded onto an acurate neo2 transfemoral (tf) delivery system (ds) in accordance with the ifu.The acurate neo2 tf ds was advanced into position.The acurate neo2 valve opened normally with deployment.The acurate neo2 valve was successfully implanted to treat the native aortic annulus.The handle of the acurate neo2 tf ds was turned to prepare the acurate neo2 tf ds for removal from the patient.During withdrawal of the acurate neo2 tf ds, the acurate neo2 tf ds interacted with the tip of the 14f isleeve introducer sheath and the acurate neo2 tf ds was unable to be withdrawn through the 14f isleeve introducer sheath.The physicians turned the handle of the acurate neo2 tf ds to reopen the distal end of the acurate neo2 tf ds in an attempt to free the devices.The physicians turned the handle of the acurate neo2 tf ds again to reclose the acurate neo2 tf ds and were eventually able to successfully remove the acurate neo2 tf ds and isleeve from the patient as a unit.An iliac artery dissection with leakage was noted.Patient status: after an unspecified intervention by the physicians, the patient's condition was stable and there was no need for further intervention by the vascular surgeon.The patient continues to be monitored.
 
Manufacturer Narrative
Patient year of birth: 1939.
 
Event Description
It was reported that difficulty removing the delivery system through the introducer sheath and dissection occurred.Procedure summary: vascular access was obtained via a transfemoral approach.The severely calcified native aortic annulus was 21.9mm in diameter and mildly tortuous.A 14f isleeve introducer sheath was advanced into position.Balloon aortic valvuloplasty (bav) was performed with a non-bsc balloon catheter in accordance with the instructions for use (ifu).An acurate neo2 valve was prepared and loaded onto an acurate neo2 transfemoral (tf) delivery system (ds) in accordance with the ifu.The acurate neo2 tf ds was advanced into position.The acurate neo2 valve opened normally with deployment.The acurate neo2 valve was successfully implanted to treat the native aortic annulus.The handle of the acurate neo2 tf ds was turned to prepare the acurate neo2 tf ds for removal from the patient.During withdrawal of the acurate neo2 tf ds, the acurate neo2 tf ds interacted with the tip of the 14f isleeve introducer sheath and the acurate neo2 tf ds was unable to be withdrawn through the 14f isleeve introducer sheath.The physicians turned the handle of the acurate neo2 tf ds to reopen the distal end of the acurate neo2 tf ds in an attempt to free the devices.The physicians turned the handle of the acurate neo2 tf ds again to reclose the acurate neo2 tf ds and were eventually able to successfully remove the acurate neo2 tf ds and isleeve from the patient as a unit.An iliac artery dissection with leakage was noted.Patient status: after an unspecified intervention by the physicians, the patient's condition was stable and there was no need for further intervention by the vascular surgeon.The patient continues to be monitored.It was further reported that the patients condition remained stable and there were no other complications.The patient was discharged from the hospital a week post procedure.
 
Manufacturer Narrative
H3 device evaluated by mfr: the returned product consisted of the 14f isleeve introducer sheath without the dilator.The cap, sheath, and tip of the 14f isleeve introducer sheath were visually and microscopically examined.Inspection of the isleeve 14f sheath revealed that there was blood inside the isleeve 14f sheath.The isleeve 14f sheath was buckled 13.5cm to 16.5cm and 24cm to 31cm distal of the strain relief.All three of the seams of the 14f isleeve introducer sheath were expanded.The damage to the shaft and tip of the isleeve 14f sheath was consistent with resistance and manipulation while being used in the patient.It was most likely that the tip was damaged and torn upon withdrawal of the acruate neo2 transfemoral delivery system, the acruate neo2 transfemoral delivery system had interacted with the torn part of the isleeve 14f sheath tip.A single angiogram image was provided and was reviewed by a bsc quality engineer.The image showed the acurate neo2 tf ds in the abdominal aorta after the acurate neo2 valve release.The acurate neo2 tf ds had been partially withdrawn into the 14f isleeve introducer sheath with the radiopaque tip of the 14f isleeve introducer sheath appearing to be damaged.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ISLEEVE 14F
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key15962609
MDR Text Key307795717
Report Number2124215-2022-36232
Device Sequence Number1
Product Code DYB
Combination Product (y/n)N
Reporter Country CodePL
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/22/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number10445
Device Catalogue Number10445
Device Lot Number0029830813
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/13/2022
Initial Date FDA Received12/12/2022
Supplement Dates Manufacturer Received12/08/2022
Supplement Dates FDA Received12/22/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/26/2022
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age82 YR
Patient SexFemale
-
-